FBInvestor
Stocks / Tango Therapeutics Inc
Institutional Ownership

Tango Therapeutics Inc

CUSIP 87583X109COMTNGXQ1 2026

13D / 13G Filings
52
Schedule 13D/13G on record
Beneficial Filers
22
Distinct reporting persons
Largest Stake
22.1%
Max % of class reported
Institutional Holders
188
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

52 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Tcg Crossover Gp II, L.P.13G/A11.0%13.52MSEC
2Feb 17, 2026Ecor1 Capital, LLC13G/A1.0KSEC
3Feb 17, 2026Woodline Partners LP13G/A7.5%10.07MSEC
4Feb 13, 2026Invus Public Equities, L.P.13G/A6.1%8.17MSEC
5Feb 12, 2026Adage Capital Management, L.P.13G7.9%10.61MSEC
6Feb 10, 2026Third Rock Ventures IV, L.P.13D/A4.7%SEC
7Feb 6, 2026Farallon Capital Partners, L.P.13G/A10.0%13.46MSEC
8Jan 30, 2026The Vanguard Group13G5.0%6.75MSEC
9Jan 21, 2026Blackrock, Inc.13G6.3%8.48MSEC
10Nov 21, 2025Third Rock Ventures IV, L.P.13D/A5.8%SEC

42 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Tango Therapeutics Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Rtw Investments, LP13.30M$278.25M
2Adage Capital Partners Gp, L.L.C.12.81M$267.97M
3Boxer Capital Management, LLC10.88M$227.53M
4Tcg Crossover Management, LLC10.53M$220.31M
5Fmr LLC9.91M$207.23M
6Farallon Capital Management LLC9.10M$190.32M
7Blackrock, Inc.8.75M$183.01M
8Woodline Partners LP8.00M$167.36M
9Nextech Invest, Ltd.7.27M$152.01M
10Trv Gp IV, LLC6.37M$133.36M